title: Wells' syndrome with a clinicopathological correlation associated with mantle-cell lymphoma.
authors.affiliation: a Second Department of Internal Medicine, 'ATTIKON' General University Hospital, Medical School , University of Athens , Greece ;
authors.forename: Ilias
authors.initials: I
authors.lastname: Pessach
authors.affiliation: a Second Department of Internal Medicine, 'ATTIKON' General University Hospital, Medical School , University of Athens , Greece ;
authors.forename: Kyriaki
authors.initials: K
authors.lastname: Petevi
authors.affiliation: a Second Department of Internal Medicine, 'ATTIKON' General University Hospital, Medical School , University of Athens , Greece ;
authors.forename: Kostas
authors.initials: K
authors.lastname: Gkirkas
authors.affiliation: a Second Department of Internal Medicine, 'ATTIKON' General University Hospital, Medical School , University of Athens , Greece ;
authors.forename: Maria
authors.initials: M
authors.lastname: Stamouli
authors.affiliation: b Department of Pathology , Evaggelismos General Hospital , Athens , Greece.
authors.forename: Pavlos
authors.initials: P
authors.lastname: Constantinou
authors.affiliation: b Department of Pathology , Evaggelismos General Hospital , Athens , Greece.
authors.forename: Dimitra
authors.initials: D
authors.lastname: Rontogianni
authors.affiliation: a Second Department of Internal Medicine, 'ATTIKON' General University Hospital, Medical School , University of Athens , Greece ;
authors.forename: Georgios
authors.initials: G
authors.lastname: Dimitriadis
authors.affiliation: a Second Department of Internal Medicine, 'ATTIKON' General University Hospital, Medical School , University of Athens , Greece ;
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Tsirigotis
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone